AstraZeneca Canada Inc. et al. v Sandoz Canada Inc.
2020
T-28-20
Pending
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,402,894 (saxagliptin)
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team
![Warren Sprigings](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0b602718f3580ecb0cc1e_warren-bw-min.jpg)
Warren Sprigings
Partner
![Mingquan Zhang, Ph.D.](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0bad553dd20fa3025675b_ming-bw-min.jpeg)
Mingquan Zhang, Ph.D.
Associate